Division of Allergic Diseases, Mayo Clinic, Rochester, Minn.
Division of Allergy and Clinical Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.
J Allergy Clin Immunol Pract. 2023 Dec;11(12):3606-3613.e2. doi: 10.1016/j.jaip.2023.07.050. Epub 2023 Aug 12.
Progestogen hypersensitivity (PH) is a heterogeneous disease characterized by diverse cutaneous manifestations, bronchospasm, and/or anaphylaxis. Possible triggers include ovarian progesterone and exogenous progestogens. The timing of symptoms is critical to diagnose PH: during the luteal phase of the menstrual cycle for the endogenous form and after exposure to progestins for exogenous PH. Diagnostic modalities such as progesterone skin testing have low sensitivity and specificity for PH. When exogenous PH is suspected, the allergist should consider a progestogen challenge. Treatment strategies should be tailored for each patient, including symptom-directed therapies, ovulation suppression, and progesterone desensitization. Future studies should explore the mechanisms of PH, validation of diagnostic criteria, and standardization of treatment strategies.
孕激素过敏症(PH)是一种以不同皮肤表现、支气管痉挛和/或过敏反应为特征的异质性疾病。可能的触发因素包括卵巢孕激素和外源性孕激素。诊断 PH 的关键是症状出现的时间:对于内源性 PH,出现在月经周期的黄体期;对于外源性 PH,出现在接触孕激素之后。孕激素皮肤试验等诊断方法对 PH 的敏感性和特异性均较低。当怀疑外源性 PH 时,过敏症医生应考虑孕激素激发试验。治疗策略应针对每位患者量身定制,包括对症治疗、排卵抑制和孕激素脱敏。未来的研究应探讨 PH 的发病机制、诊断标准的验证以及治疗策略的标准化。